Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
54.17
+0.30 (0.56%)
At close: Mar 9, 2026, 4:00 PM EDT
54.24
+0.07 (0.13%)
After-hours: Mar 9, 2026, 7:22 PM EDT
Supernus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 128.45 | 69.33 | 75.05 | 93.12 | 203.43 | Upgrade
|
| Short-Term Investments | 180.22 | 384.28 | 179.82 | 368.21 | 136.25 | Upgrade
|
| Cash & Short-Term Investments | 308.67 | 453.61 | 254.87 | 461.33 | 339.68 | Upgrade
|
| Cash Growth | -31.95% | 77.98% | -44.75% | 35.81% | -19.61% | Upgrade
|
| Receivables | 187.8 | 142.08 | 144.16 | 165.5 | 148.93 | Upgrade
|
| Inventory | 82.39 | 54.29 | 77.41 | 91.54 | 85.96 | Upgrade
|
| Prepaid Expenses | 65.33 | 36.09 | 16.68 | 15.78 | 27.02 | Upgrade
|
| Total Current Assets | 644.18 | 686.07 | 493.11 | 734.15 | 601.59 | Upgrade
|
| Property, Plant & Equipment | 37.24 | 36.02 | 42.52 | 44.08 | 52.32 | Upgrade
|
| Long-Term Investments | - | - | 16.62 | 93.9 | 119.17 | Upgrade
|
| Goodwill | 124.88 | 117.02 | 117.02 | 117.02 | 117.52 | Upgrade
|
| Other Intangible Assets | 569.46 | 521.91 | 599.89 | 702.46 | 784.69 | Upgrade
|
| Long-Term Deferred Tax Assets | 38.35 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 38.53 | 7.05 | 8.51 | 10.9 | 13.87 | Upgrade
|
| Total Assets | 1,453 | 1,368 | 1,278 | 1,703 | 1,689 | Upgrade
|
| Accounts Payable | 2.68 | 4.59 | 1.96 | 10.54 | 9.33 | Upgrade
|
| Accrued Expenses | 217.81 | 180.21 | 166.26 | 185.67 | 199.47 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 407.97 | 7.24 | Upgrade
|
| Current Portion of Leases | 10.61 | 6.89 | 8.33 | 6.79 | 6.48 | Upgrade
|
| Other Current Liabilities | 107.07 | 100.72 | 113.64 | 76.99 | 92.86 | Upgrade
|
| Total Current Liabilities | 338.17 | 292.4 | 290.2 | 687.96 | 315.38 | Upgrade
|
| Long-Term Debt | - | - | - | - | 385.23 | Upgrade
|
| Long-Term Leases | 30.37 | 27.38 | 33.2 | 36 | 41.3 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 4.96 | 24.96 | 49.81 | 85.36 | Upgrade
|
| Other Long-Term Liabilities | 22.4 | 7.6 | 7.8 | 42.54 | 46.04 | Upgrade
|
| Total Liabilities | 390.93 | 332.34 | 356.16 | 816.3 | 873.3 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 543.83 | 479.44 | 439.49 | 408.12 | 434.34 | Upgrade
|
| Retained Earnings | 517.88 | 556.43 | 482.56 | 481.25 | 379.92 | Upgrade
|
| Comprehensive Income & Other | -0.04 | -0.19 | -0.59 | -3.21 | 1.54 | Upgrade
|
| Shareholders' Equity | 1,062 | 1,036 | 921.52 | 886.2 | 815.85 | Upgrade
|
| Total Liabilities & Equity | 1,453 | 1,368 | 1,278 | 1,703 | 1,689 | Upgrade
|
| Total Debt | 40.98 | 34.27 | 41.53 | 450.76 | 440.25 | Upgrade
|
| Net Cash (Debt) | 267.69 | 419.34 | 229.96 | 104.47 | 18.6 | Upgrade
|
| Net Cash Growth | -36.16% | 82.35% | 120.12% | 461.74% | -94.47% | Upgrade
|
| Net Cash Per Share | 4.74 | 7.49 | 4.14 | 1.69 | 0.34 | Upgrade
|
| Filing Date Shares Outstanding | 57.58 | 55.81 | 54.73 | 54.38 | 53.39 | Upgrade
|
| Total Common Shares Outstanding | 57.46 | 55.74 | 54.72 | 54.25 | 53.26 | Upgrade
|
| Working Capital | 306.01 | 393.67 | 202.92 | 46.19 | 286.21 | Upgrade
|
| Book Value Per Share | 18.48 | 18.58 | 16.84 | 16.33 | 15.32 | Upgrade
|
| Tangible Book Value | 367.38 | 396.8 | 204.61 | 66.72 | -86.36 | Upgrade
|
| Tangible Book Value Per Share | 6.39 | 7.12 | 3.74 | 1.23 | -1.62 | Upgrade
|
| Machinery | 14.87 | 14.48 | 14.03 | 13.11 | 14.23 | Upgrade
|
| Construction In Progress | - | - | - | 0.21 | 0.03 | Upgrade
|
| Leasehold Improvements | 13.05 | 14.02 | 14.02 | 14.02 | 14.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.